Cargando…
Tecovirimat use among patients with monkeypox (mpox) in Alameda County, California, June–October 2022
Background: Tecovirimat (TPOXX) is an antiviral drug only available via an Expanded Access Program (EAP) investigational new drug protocol and is recommended for treatment of select patients with monkeypox (mpox) infection. Alameda County Public Health Department prioritizes health equity but does n...
Autores principales: | Ouyang, Megan, Shemsu, Munira, Marusinec, Rachel, Pena, April, Trivedi, Kavita, Dunne, Eileen, Yette, Emily, Moss, Nicholas, Bayard, Paul, Edmunds, Magdalen, Lai, Sunny, Nguyen, Mychi, Rajagopal, Sumanth, Slome, Sally, Tang, Michele, Ayala, George, Chitnis, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594300/ http://dx.doi.org/10.1017/ash.2023.379 |
Ejemplares similares
-
Tecovirimat for monkeypox
por: Halani, Sheliza, et al.
Publicado: (2022) -
Tecovirimat for the treatment of severe Mpox in Germany
por: Hermanussen, Lennart, et al.
Publicado: (2023) -
Monkeypox treatment: Is tecovirimat the answer?
por: Niaz, Faizan, et al.
Publicado: (2022) -
Tecovirimat Resistance in Mpox Patients, United States, 2022–2023
por: Smith, Todd G., et al.
Publicado: (2023) -
Outbreak of Stenotrophomonas maltophilia infections in an intensive care unit—Alameda County, California, May–October 2022
por: Elliott, Rebeca, et al.
Publicado: (2023)